141 related articles for article (PubMed ID: 25614895)
21. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
22. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.
Bravenboer B; Kappelle AC; van Buren T; Erkelens DW; Gispen WH
Acta Diabetol; 1993; 30(1):21-4. PubMed ID: 8392402
[TBL] [Abstract][Full Text] [Related]
23. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats.
Rodrigues Filho OA; Fazan VP
J Neurosci Methods; 2006 Mar; 151(2):131-8. PubMed ID: 16125783
[TBL] [Abstract][Full Text] [Related]
24. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
25. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
26. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
Nangle MR; Gibson TM; Cotter MA; Cameron NE
Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
[TBL] [Abstract][Full Text] [Related]
27. Sciatic nerve lipoprotein lipase is reduced in streptozotocin-induced diabetes and corrected by insulin.
Ferreira LD; Huey PU; Pulford BE; Ishii DN; Eckel RH
Endocrinology; 2002 Apr; 143(4):1213-7. PubMed ID: 11897675
[TBL] [Abstract][Full Text] [Related]
28. Effect of lacidipine pre-treatment on diabetic neuropathy in rats.
Singh J; Aditya S; Lal H; Arora B
Arch Physiol Biochem; 2011 Feb; 117(1):12-7. PubMed ID: 21091185
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats.
Sameni HR; Panahi M; Sarkaki A; Saki GH; Makvandi M
Pak J Biol Sci; 2008 Aug; 11(16):1994-2000. PubMed ID: 19266905
[TBL] [Abstract][Full Text] [Related]
30. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
Malone JI; Lowitt S; Corsico N; Orfalian Z
Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
[TBL] [Abstract][Full Text] [Related]
31. Transplantation of dental pulp stem cells improves long-term diabetic polyneuropathy together with improvement of nerve morphometrical evaluation.
Omi M; Hata M; Nakamura N; Miyabe M; Ozawa S; Nukada H; Tsukamoto M; Sango K; Himeno T; Kamiya H; Nakamura J; Takebe J; Matsubara T; Naruse K
Stem Cell Res Ther; 2017 Dec; 8(1):279. PubMed ID: 29237486
[TBL] [Abstract][Full Text] [Related]
32. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
33. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
Kandhare AD; Raygude KS; Ghosh P; Ghule AE; Bodhankar SL
Fitoterapia; 2012 Jun; 83(4):650-9. PubMed ID: 22343014
[TBL] [Abstract][Full Text] [Related]
36. Oxytocin provides protection against diabetic polyneuropathy in rats.
Erbas O; Taşkıran D; Oltulu F; Yavaşoğlu A; Bora S; Bilge O; Çınar BP; Peker G
Neurol Res; 2017 Jan; 39(1):45-53. PubMed ID: 27881053
[TBL] [Abstract][Full Text] [Related]
37. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
38. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy.
Kanter M
Neurochem Res; 2008 Jan; 33(1):87-96. PubMed ID: 17713854
[TBL] [Abstract][Full Text] [Related]
39. Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences.
Li M; Li Q; Zhao Q; Zhang J; Lin J
Int J Clin Exp Pathol; 2015; 8(9):10112-20. PubMed ID: 26617718
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
